Cargando…

Ghrelin rescues skeletal muscle catabolic profile in the R6/2 mouse model of Huntington’s disease

Accumulating evidence suggests altered energy metabolism as a key feature in Huntington’s disease (HD) pathology. Hyper-catabolism, including weight loss and muscle atrophy, is seen in HD patients and HD mouse models. Metabolic hormones are key players, not only in energy metabolism, but also in neu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sjögren, Marie, Duarte, Ana I., McCourt, Andrew C., Shcherbina, Liliya, Wierup, Nils, Björkqvist, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654969/ https://www.ncbi.nlm.nih.gov/pubmed/29066728 http://dx.doi.org/10.1038/s41598-017-13713-5

Ejemplares similares

Dual Therapy with Liraglutide and Ghrelin Promotes Brain and Peripheral Energy Metabolism in the R6/2 Mouse Model of Huntington’s Disease
por: Duarte, Ana I., et al.
Publicado: (2018)

Ghrelin Is a Regulator of Glucagon-Like Peptide 1 Secretion and Transcription in Mice
por: Lindqvist, Andreas, et al.
Publicado: (2017)

White Adipose Tissue Browning in the R6/2 Mouse Model of Huntington’s Disease
por: McCourt, Andrew C., et al.
Publicado: (2016)

Characterization of Gastric Mucosa Biopsies Reveals Alterations in Huntington's Disease
por: McCourt, Andrew C, et al.
Publicado: (2015)

Increased intestinal permeability and gut dysbiosis in the R6/2 mouse model of Huntington’s disease
por: Stan, Tiberiu Loredan, et al.
Publicado: (2020)

Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington’s disease R6/2 mice
por: Soylu-Kucharz, Rana, et al.
Publicado: (2017)

Effects of excitotoxicity in the hypothalamus in transgenic mouse models of Huntington disease
por: Henningsen, Jo B., et al.
Publicado: (2021)

Skeletal muscle pathology in Huntington's disease
por: Zielonka, Daniel, et al.
Publicado: (2014)

Intramuscular injection of mesenchymal stem cells activates anabolic and catabolic systems in mouse skeletal muscle
por: Takegaki, Junya, et al.
Publicado: (2021)

Altered Ca(2+) signaling in skeletal muscle fibers of the R6/2 mouse, a model of Huntington’s disease
por: Braubach, Peter, et al.
Publicado: (2014)

Euploidy in somatic cells from R6/2 transgenic Huntington's disease mice
por: Petersén, Åsa, et al.
Publicado: (2005)

The effects of diet and chronic exercise on skeletal muscle ghrelin response
por: Lovell, Andrew J., et al.
Publicado: (2022)

Huntington’s disease skeletal muscle has altered T-tubules
por: Khan, Muhammad S., et al.
Publicado: (2021)

Effects of Exercise on Skeletal Muscle Pathophysiology in Huntington’s Disease
por: Trovato, Bruno, et al.
Publicado: (2022)

Transcriptional Signature of an Altered Purine Metabolism in the Skeletal Muscle of a Huntington's Disease Mouse Model
por: Mielcarek, Michal, et al.
Publicado: (2017)

Ablation of Ghrelin Receptor Mitigates the Metabolic Decline of Aging Skeletal Muscle
por: O’Reilly, Colleen, et al.
Publicado: (2022)

Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models
por: Dickson, Elna, et al.
Publicado: (2022)

A mouse model of Huntington’s disease shows altered ultrastructure of transverse tubules in skeletal muscle fibers
por: Romer, Shannon H., et al.
Publicado: (2021)

Branched-chain Amino Acids: Catabolism in Skeletal Muscle and Implications for Muscle and Whole-body Metabolism
por: Mann, Gagandeep, et al.
Publicado: (2021)

Rescuing the Corticostriatal Synaptic Disconnection in the R6/2 Mouse Model of Huntington’s Disease: Exercise, Adenosine Receptors and Ampakines
por: Cepeda, Carlos, et al.
Publicado: (2010)

A Critical Evaluation of Wet Biomarkers for Huntington’s Disease: Current Status and Ways Forward
por: Silajdžić, Edina, et al.
Publicado: (2018)

Restoring GABAergic inhibition rescues memory deficits in a Huntington’s disease mouse model
por: Dargaei, Zahra, et al.
Publicado: (2018)

Centrally and peripherally altered glucose transporters: is it time to revisit energy deficiency as a potential treatment strategy in Huntington's disease?
por: Björkqvist, Maria
Publicado: (2023)

Myostatin inhibition prevents skeletal muscle pathophysiology in Huntington’s disease mice
por: Bondulich, Marie K., et al.
Publicado: (2017)

Ablation of kynurenine 3-monooxygenase rescues plasma inflammatory cytokine levels in the R6/2 mouse model of Huntington’s disease
por: Bondulich, Marie Katrin, et al.
Publicado: (2021)

The metabolic and molecular mechanisms of hyperammonaemia‐ and hyperethanolaemia‐induced protein catabolism in skeletal muscle cells
por: Crossland, Hannah, et al.
Publicado: (2018)

Progressive Cl(−) channel defects reveal disrupted skeletal muscle maturation in R6/2 Huntington’s mice
por: Miranda, Daniel R., et al.
Publicado: (2017)

Genetic deletion of S6k1 does not rescue the phenotypic deficits observed in the R6/2 mouse model of Huntington’s disease
por: Irvine, Elaine E., et al.
Publicado: (2019)

Abnormal peripheral chemokine profile in Huntington’s disease
por: Wild, Edward, et al.
Publicado: (2011)

Effects of endurance training on skeletal muscle mitochondrial function in Huntington disease patients
por: Mueller, Sandro Manuel, et al.
Publicado: (2017)

Skeletal Muscle Modulates Huntington’s Disease Pathogenesis in Mice: Role of Physical Exercise
por: Corrochano, Silvia, et al.
Publicado: (2018)

Rosiglitazone Ameliorates Cardiac and Skeletal Muscle Dysfunction by Correction of Energetics in Huntington’s Disease
por: Tomczyk, Marta, et al.
Publicado: (2022)

Reactive Oxygen and Nitrogen Species Regulate Key Metabolic, Anabolic, and Catabolic Pathways in Skeletal Muscle
por: Nemes, Roland, et al.
Publicado: (2018)

Low-Grade Systemic Inflammation Interferes with Anabolic and Catabolic Characteristics of the Aged Human Skeletal Muscle
por: Draganidis, Dimitrios, et al.
Publicado: (2021)

Acylated and unacylated ghrelin do not directly stimulate glucose transport in isolated rodent skeletal muscle
por: Cervone, Daniel T., et al.
Publicado: (2017)

Hypothalamic expression of huntingtin causes distinct metabolic changes in Huntington's disease mice
por: Dickson, Elna, et al.
Publicado: (2022)

Dissecting the Complexity of Skeletal-Malocclusion-Associated Phenotypes: Mouse for the Rescue
por: Lone, Iqbal M., et al.
Publicado: (2023)

Fast-to-Slow Transition of Skeletal Muscle Contractile Function and Corresponding Changes in Myosin Heavy and Light Chain Formation in the R6/2 Mouse Model of Huntington’s Disease
por: Hering, Tanja, et al.
Publicado: (2016)

JAK/STAT Signalling in Huntington’s Disease Immune Cells
por: Träger, Ulrike, et al.
Publicado: (2013)

Metabotropic glutamate receptor 5 knockout rescues obesity phenotype in a mouse model of Huntington’s disease
por: Santos, Rebeca P. M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n5kvbuqva2oec08jeg1uru827u